Cannabis Law and Legislation in Zimbabwe: A Complete Guide

Zimbabwe was one of the first African countries to create a formal legal pathway for medicinal cannabis production. At the same time, recreational use, possession, and unlicensed cultivation remain strictly prohibited and carry significant criminal penalties. The country has also developed a separate regulatory track for industrial hemp. Understanding the distinction between these regimes is essential for anyone interested in the legal status of cannabis or hemp in Zimbabwe.

This article provides a clear, up-to-date overview of cannabis law and legislation in Zimbabwe as of 2026. It covers the 2018 medicinal cannabis regulations, the industrial hemp framework, what remains illegal, licensing requirements, local versus export rules, recent fee reforms, and practical implications for businesses and individuals.

Overall Legal Position

Recreational (adult-use) cannabis is illegal in Zimbabwe. Possession, use, cultivation, and supply outside the licensed medicinal or industrial hemp channels are criminal offences under the Dangerous Drugs Act and the Criminal Law (Codification and Reform) Act. Penalties can be severe, with reports of sentences of up to 10–12 years’ imprisonment for unlawful possession or use, and potentially heavier penalties for trafficking.

In 2018, Zimbabwe created a tightly controlled commercial licensing system for the production of cannabis for medicinal and scientific purposes. A separate framework for industrial hemp followed. These pathways allow licensed cultivation and related activities, but they do not legalise personal possession or recreational consumption by the general public.

Medicinal and Scientific Cannabis: Statutory Instrument 62 of 2018

The cornerstone of Zimbabwe’s medicinal cannabis regime is the Dangerous Drugs (Production of Cannabis for Medicinal and Scientific Use) Regulations, 2018 (Statutory Instrument 62 of 2018). These regulations were made under the Dangerous Drugs Act and are administered by the Medicines Control Authority of Zimbabwe (MCAZ) on behalf of the Ministry of Health and Child Care.

SI 62 of 2018 legalised the production of cannabis for medicinal and scientific uses only. It created two main categories of licence:

• Cultivation and Research of Cannabis — focused on research and development activities.
• Cultivation and Production of Cannabis — allowing production for export as well as research and development.

Licences are valid for five years from the date of issue and are renewable. Each licence applies to a single cultivation site; a separate licence is required for additional sites or for certain processing activities at different locations.

Important Limitations on Local Use

Under the current framework, cannabis produced in Zimbabwe under these licences is primarily intended for export. Local use of cannabis produced in the country is restricted to research and development purposes. There is no broad domestic medical-access programme that allows ordinary patients to obtain cannabis products from pharmacies or dispensaries in the same way as in some other jurisdictions. Some value-added CBD products have begun to appear in the market under complementary-medicine or consumer-product categories, but these remain subject to MCAZ oversight.

Definition and Distinction from Hemp

Medicinal cannabis is distinguished from industrial hemp primarily by THC content. According to Zimbabwean law (including updates in the Criminal Law (Codification and Reform) Amendment Act 2023), industrial hemp is defined as the plant Cannabis sativa L. and any part of that plant (including seeds, derivatives, extracts, cannabinoids, etc.) with a delta-9-tetrahydrocannabinol concentration of not more than 1% on a dry-weight basis. Material above that threshold falls under the medicinal cannabis regime when produced under licence.

The MCAZ operates a dedicated Cannabis Laboratory that tests total THC content of cannabis and industrial hemp samples intended for use or export.

Industrial Hemp Framework

Industrial hemp is regulated separately from high-THC medicinal cannabis. Statutory Instrument 218 of 2019 / 2020 (Agricultural Marketing Authority (Industrial Hemp) Regulations) established a framework for the production, procurement, distribution, possession, sale, and transportation of industrial hemp.

Key features include:

• Oversight by the Agricultural Marketing Authority (AMA) and the Ministry responsible for lands and agriculture.
• A THC threshold of not more than 1% (higher than the 0.3% limit used in many other jurisdictions).
• Several permit types, including general cultivator’s permits, research and breeding permits, and industrial hemp merchant’s permits.
• Requirements for certified seed, cultivation practices, labelling, transportation, and post-harvest destruction of non-compliant material.

The government has actively encouraged the commercialisation of industrial hemp. Field days, pilot projects, and statements from the AMA in 2026 have emphasised the need to move from regulatory setup to scaled production and market development. Cultivation activity has been reported in provinces such as Mashonaland, with targets for expanded hectareage.

Domestic retail of certain hemp-derived consumer products can still face constraints under MCAZ rules that treat many cannabinoid products as medicinal substances. Export of compliant industrial hemp material is permitted under licence, subject to customs and regulatory inspections.

Licensing Costs and Recent Reforms

Entry into the medicinal cannabis sector has historically involved significant fees. Earlier figures included substantial application and licence fees (commonly cited in the range of tens of thousands of US dollars for production licences), annual returns, and inspection costs. Research licences were generally less expensive than full production licences.

In 2026 the government announced reforms aimed at streamlining licences and reducing certain fees to lower the cost of doing business. Cabinet-approved measures included reductions in industrial hemp registration and application fees administered by the AMA and MCAZ, as well as reductions in medicinal cannabis research permit fees. These changes form part of a broader effort to attract investment, create jobs, and boost exports while maintaining regulatory control.

Prospective applicants should obtain the latest fee schedule and application requirements directly from the MCAZ (for medicinal cannabis) or the AMA (for industrial hemp), as amounts and procedures can be updated.

What Remains Illegal

The following activities remain prohibited and can attract criminal sanctions:

• Possession, use, or cultivation of cannabis for personal or recreational purposes
• Any unlicensed cultivation, production, or supply of high-THC cannabis
• Dealing or trafficking outside the authorised channels
• Public consumption
• Possession or supply involving minors

The existence of a licensed medicinal or hemp sector does not create a general right for individuals to grow or possess cannabis at home. Unlicensed activity continues to be treated as a criminal offence under the Dangerous Drugs Act and related criminal legislation.

Enforcement and Practical Realities

Enforcement is carried out by the Zimbabwe Republic Police, including specialised drug units. Travel advisories from foreign governments consistently warn that drug offences, including cannabis possession, can result in long prison sentences and heavy fines. Visitors and residents should not assume that limited enforcement in some areas means the law is not applied.

At the same time, the licensed sector has seen tangible activity. Processing facilities have been established, value-added CBD products (including distillates, isolates, and certain consumer formulations) have been produced, and both medicinal cannabis and industrial hemp projects have moved from pilots toward commercial scale. The government’s policy emphasis under national development strategies has been on beneficiation (value addition) rather than the export of raw biomass alone.

Summary Table: Legal Status at a Glance

Practical Guidance for Businesses and Investors

Anyone considering participation in the Zimbabwean cannabis or hemp sector should note the following:

• Only activities covered by a valid MCAZ or AMA authorisation are lawful.
• Medicinal cannabis licences are site-specific and subject to ongoing compliance, security, and quality requirements.
• Industrial hemp operates under a distinct agricultural permitting system with its own rules on seed, cultivation, and marketing.
• Fee reductions announced in 2026 may improve the commercial environment, but capital, compliance, and market-access costs remain significant.
• Local legal and regulatory advice is essential before committing resources.

The framework prioritises controlled, industrial-scale production oriented toward export and research. It is not designed as a smallholder or personal-use system.

Conclusion

Zimbabwe maintains a dual-track approach: a licensed, tightly regulated pathway for medicinal cannabis and industrial hemp, and continued criminalisation of recreational use and unlicensed activity. Statutory Instrument 62 of 2018 opened the medicinal and scientific production door, while subsequent industrial hemp regulations created a separate agricultural route with a relatively high 1% THC threshold. Local use of cannabis produced under these licences remains restricted, with the primary orientation toward export and research.

Recent government efforts to reduce certain licensing fees and encourage commercialisation of hemp signal an interest in growing the sector’s economic contribution. At the same time, the criminal prohibitions on personal possession and recreational use remain firmly in place and carry serious penalties.

As with any regulated industry, the practical details of fees, application processes, and compliance expectations can change. Interested parties should consult the latest official materials from the Medicines Control Authority of Zimbabwe and the Agricultural Marketing Authority, and obtain professional legal advice before taking any steps that involve cannabis or hemp plants or products.

At CBD Africa we provide educational information on cannabis and hemp regulation across the continent. This article is intended for general information only and does not constitute legal advice. Always verify current requirements with the competent Zimbabwean authorities and qualified advisors.